Scynexis Prepares To Launch Brexafemme In Vaginal Yeast Infections, Priced At $475

 
• By Joseph Haas
Rocket takes off from the hand of the businessman. Concept of start up.
Scynexis is readying launch of its novel anti-fungal for vaginal yeast infections

More from Strategy

More from Business